Cellenkos, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-06
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: REGALS · Regulatory T Cells for Amyotrophic Lateral Sclerosis Primary completion pushed from May 2026 to May 2027
- Notable: TREG108 · Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs Primary completion pushed from Apr 30, 2026 to Apr 30, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 3 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 |
Disease areas by active trials
ALS (1) · Myelofibrosis (1)
Get alerts when Cellenkos, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.